Sun Pharma raises Rs 7,816 crore, misses bond target

The Quick Take
Sun Pharma successfully secured ₹7,816 crore in its latest fundraising round, yet it fell short of its ambitious ₹10,000-crore target. The company opted for five- and seven-year bonds, pricing them at 8.05% and 8.20% respectively. A significant ₹2,100 crore was raised through anchor investments to bolster this effort, although rising market yields have made investors cautious about committing fund
Ground Level News gathers headlines from public news feeds. This page shows a short summary only; the full article and all rights belong to Economic Times.


